



CorNeat gPatch
Permanent periodontal regeneration membrane
CorNeat gPatch
The CorNeat gPatch is the first permanent & tissue-integrating periodontal surgical matrix for Guided Bone Regeneration (GBR) and gingival recession surgeries.
An optimal GBR membrane
The features and benefits of the CorNeat gPatch position it as an optimal membrane for GBR, a common procedure performed to rebuild the alveolar ridge and enable it to support a tooth implant. The CorNeat gPatch combines the advantages of non-degradable membranes, such as high tensile strength, malleability, ease of handling and suturing, resulting in better bone regeneration control, together with resorbable membranes and ECMs, including better biocompatibility and bio-integration in a single surgery.
The CorNeat gPatch is fully synthetic, hence it cannot carry or transmit disease. From a logistical perspective this allows for a long shelf life, easing regulatory hurdles related to transportation.
The only permanent gingival reinforcement patch
Current solutions for gingival recession (around teeth or dental implants) rely on the use of autografts, allografts/xenografts, or collagen matrices, which are sutured over the exposed area and then covered by a flap of soft gingival tissue. Unlike these grafts and collagen matrices that are absorbed over time, yielding poor long-term results, the CorNeat gPatch provides, for the first time, a permanent infrastructure for gingival tissue regeneration. It is the only “scaffold” that remains in the tissue for life and, once bio-integrated, provides long lasting mechanical support to surrounding tissue. It is poised to disrupt the gingival soft tissue repair market and revolutionize current treatment.


CorNeat gPatch Advantages

Permanency
Provides permanent support throughout the healing process
-
Does not require excision post-op

Promotes Healing
Stimulates cellular growth
-
Maintains nutrient flow, better bone growth and integration

Durable/Flexible
Tear resistant
-
Stretchable
-
Space maintainer

Ease of Use
Easily cut, fixated and sutured to target site
Regulatory Path
The CorNeat gPatch has successfully completed several proofs of concepts and was proven safe and effective in subcutaneous and sub-gingival implantations. Biocompatibility tests and additional pre-clinical in vivo trials, which include a (large) animal GLP implantation study, are planned towards obtaining FDA 510(k) early in 2024.
The plans above are subject to regulatory approvals and requirements.